Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
- Conditions
- Osteogenesis Imperfecta
- Registration Number
- NCT00131118
- Lead Sponsor
- Novartis Pharmaceuticals
- Brief Summary
This is an extension study to examine the long-term safety and efficacy of zoledronic acid in patients who have completed the core CZOL446H2202 study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 127
- Have completed the core CZOL446H2202 study
- Males or females between 1-17 years of age
- Deformity or abnormality which would prevent spine bone density from being done
- Any surgical bone-lengthening procedure
- Any kidney diseases or abnormalities
- Low calcium or vitamin D levels in the blood
Other protocol-defined inclusion/exclusion criteria may apply.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Long-term safety of two different zoledronic acid doses over an additional 12 months in patients who have completed one year treatment in CZOL446H2202
- Secondary Outcome Measures
Name Time Method Measure percentage change of lumbar spine bone mineral density at month 18 and 24 compared to baseline in the core study.
Trial Locations
- Locations (9)
UCLA Medical Center-Dept of Pediatric Nephrology
πΊπΈLos Angeles, California, United States
Alfred Dupont Hospital for Children
πΊπΈWilmington, Delaware, United States
Intermountains Orthopedics
πΊπΈBoise, Idaho, United States
Children's Hospital
πΊπΈColumbus, Ohio, United States
For information regarding facilities, please contact the Central Contact
πΊπΈMultiple Locations, New Jersey, United States
Children's Hospital Medical Center
πΊπΈCincinnati, Ohio, United States
Oregon Health Sciences University
πΊπΈPortland, Oregon, United States
Vanderbilt University Medical Center
πΊπΈNashville, Tennessee, United States
Texas Children's Hospital
πΊπΈHouston, Texas, United States
UCLA Medical Center-Dept of Pediatric NephrologyπΊπΈLos Angeles, California, United States
